Association of Peripheral Blood Biomarkers With Response to Anti-PD-1 Immunotherapy for Patients With Deficient Mismatch Repair Metastatic Colorectal Cancer: A Multicenter Cohort Study

PURPOSE: Deficient mismatch repair (dMMR) is an established biomarker for the response to the programmed cell death (PD)-1 inhibitors in metastatic colorectal cancer (mCRC). Although patients with dMMR mCRC could achieve a high incidence of disease control and favorable progression-free survival (PF...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Yi-Kan, Chen, Dong-Wen, Chen, Ping, He, Xiaosheng, Li, Pei-Si, Lin, Zhen-Sen, Chen, Shao-Xia, Ye, Shu-Biao, Lan, Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8850282/
https://www.ncbi.nlm.nih.gov/pubmed/35185898
http://dx.doi.org/10.3389/fimmu.2022.809971

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8850282/
https://www.ncbi.nlm.nih.gov/pubmed/35185898
http://dx.doi.org/10.3389/fimmu.2022.809971

Ejemplares similares